LONDON, July 28 (Reuters) – AstraZeneca declined to
comment on Thursday on whether the drugmaker could become a
takeover target once more, two years after it saw off a bid from
Pfizer.
The post AstraZeneca a takeover target again? CEO not commenting appeared first on NASDAQ.